United Health Products partners with NAMSA for CelluSTAT clinical study
United Health Products has partnered with NAMSA to sponsor a new clinical study of its CelluSTAT Hemostatic Gauze to help resolve an outstanding FDA warning letter. This collaboration provides UHP with exclusive data rights to support a revised PMA application, advancing the path toward regulatory approval.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day